Posts Tagged ‘#genomics’

Traces of a distant past : Scientific American

December 7, 2012

http://www.nature.com/scientificamerican/journal/v299/n1/full/scientificamerican0708-56.html Gary Stix

ENCODE Nets Fig. of Allelic Regulation in Wired’s Best Scientific Figures of 2012

December 6, 2012

http://www.wired.com/wiredscience/2012/12/science-figures-2012

Long noncoding RNAs in C. elegans

December 5, 2012

http://genome.cshlp.org/content/22/12/2529.full

Article: Predicting cancer drivers: are we there yet?

December 1, 2012

http://genomemedicine.com/content/4/11/88

associated with transFIC method

Non-coding variation review

November 25, 2012

http://www.nature.com/nbt/journal/v30/n11/full/nbt.2422.html

Why rodent pseudogenes refuse to retire

November 23, 2012

http://genomebiology.com/2012/13/11/178

ENCODE summary from NIH

November 17, 2012

http://www.genome.gov/27551473

Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields.

November 5, 2012

This paper introduces a new method for detecting copy number variants in cancer genomes that addresses deficiencies of previous detection methods. The new method, dubbed HHCRF by the authors, adds the use of sequential correlations in selecting classification features for inferring copy numbers and identifying clinically relevant genes. This improvement results in higher accuracy on noisy data, and the identification of more clinically relevant genes, relative to previous methods. These results were obtained by testing HHCRF on both simulated array-CGH microarray data, and on actual breast cancer, uveal melanoma, and bladder tumor datasets.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677736/
Bioinformatics. 2009 May 15;25(10):1307-13. Epub 2008 Dec 3. Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields.
Barutcuoglu Z, Airoldi EM, Dumeaux V, Schapire RE, Troyanskaya OG.

Michael Specter: Exploring the Human Microbiome : New Yorker

November 3, 2012

– Very much argues the dirt is good case
http://www.newyorker.com/reporting/2012/10/22/121022fa_fact_specter

Cancer N/S ratio

October 20, 2012

From XJM:

A few references about nonsynonymous/synonymous ratio in Cancer: Here is a Nature paper finding nonsynonymous/synonymous ratio to be 3:1 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712719/

Here is an article reporting the ratio to be about 4:1
http://www.nature.com/ng/journal/v43/n11/full/ng.950.html

Another one:
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-148X.2012.00976.x/full

An online powerpoint reporting 2:1 ratio:
http://www.genome.gov/Pages/Research/DIR/DIRNewsFeatures/Next-Gen101/Samuels_WholeExomeSequencing.pdf